Beta Bionics and FSL3+

Beta Bionics has announced that it has partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system. The companies plan

Read More »

Top research priorities for T1D

Diabetes UK has invited hundreds of people with Type 1 diabetes, their families and healthcare professionals to choose their most pressing research priorities for Type

Read More »